Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
10.1152/ajpendo.00354.2002 Am
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
If you are currently taking anticoagulants, please consult with your physician before taking L-Carnitine
May help reduce sugar cravings and support sustained, balanced energy throughout the day
These data indicate that semaglutide alone results in weight reduction involving both fat and lean mass loss, while adding -MSTN/-ActA to semaglutide results in similar weight reduction but with profoundly beneficial effects on body composition not only by preserving/increasing lean mass but also by markedly increasing fat loss
In a foundational 2009 study, Li and colleagues found that GLP-1R stimulation preserved both cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism [5]
US$ 28.41
US$ 21.10
US$ 20.93
US$ 26.54
